Cargando…
Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase
Auranofin, a reprofiled FDA-approved drug originally designed to treat rheumatoid arthritis, has emerged as a promising anti-parasitic drug. It induces the accumulation of reactive oxygen species (ROS) in parasites, including Toxoplasma gondii. We generated auranofin resistant T. gondii lines throug...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017268/ https://www.ncbi.nlm.nih.gov/pubmed/33816332 http://dx.doi.org/10.3389/fcimb.2021.618994 |
_version_ | 1783674028774391808 |
---|---|
author | Ma, Christopher I. Tirtorahardjo, James A. Jan, Sharon Schweizer, Sakura S. Rosario, Shawn A. C. Du, Yanmiao Zhang, Jerry J. Morrissette, Naomi S. Andrade, Rosa M. |
author_facet | Ma, Christopher I. Tirtorahardjo, James A. Jan, Sharon Schweizer, Sakura S. Rosario, Shawn A. C. Du, Yanmiao Zhang, Jerry J. Morrissette, Naomi S. Andrade, Rosa M. |
author_sort | Ma, Christopher I. |
collection | PubMed |
description | Auranofin, a reprofiled FDA-approved drug originally designed to treat rheumatoid arthritis, has emerged as a promising anti-parasitic drug. It induces the accumulation of reactive oxygen species (ROS) in parasites, including Toxoplasma gondii. We generated auranofin resistant T. gondii lines through chemical mutagenesis to identify the molecular target of this drug. Resistant clones were confirmed with a competition assay using wild-type T. gondii expressing yellow fluorescence protein (YFP) as a reference strain. The predicted auranofin target, thioredoxin reductase, was not mutated in any of our resistant lines. Subsequent whole genomic sequencing analysis (WGS) did not reveal a consensus resistance locus, although many have point mutations in genes encoding redox-relevant proteins such as superoxide dismutase (TgSOD2) and ribonucleotide reductase. We investigated the SOD2 L201P mutation and found that it was not sufficient to confer resistance when introduced into wild-type parasites. Resistant clones accumulated less ROS than their wild type counterparts. Our results demonstrate that resistance to auranofin in T. gondii enhances its ability to abate oxidative stress through diverse mechanisms. This evidence supports a hypothesized mechanism of auranofin anti-parasitic activity as disruption of redox homeostasis. |
format | Online Article Text |
id | pubmed-8017268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80172682021-04-03 Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase Ma, Christopher I. Tirtorahardjo, James A. Jan, Sharon Schweizer, Sakura S. Rosario, Shawn A. C. Du, Yanmiao Zhang, Jerry J. Morrissette, Naomi S. Andrade, Rosa M. Front Cell Infect Microbiol Cellular and Infection Microbiology Auranofin, a reprofiled FDA-approved drug originally designed to treat rheumatoid arthritis, has emerged as a promising anti-parasitic drug. It induces the accumulation of reactive oxygen species (ROS) in parasites, including Toxoplasma gondii. We generated auranofin resistant T. gondii lines through chemical mutagenesis to identify the molecular target of this drug. Resistant clones were confirmed with a competition assay using wild-type T. gondii expressing yellow fluorescence protein (YFP) as a reference strain. The predicted auranofin target, thioredoxin reductase, was not mutated in any of our resistant lines. Subsequent whole genomic sequencing analysis (WGS) did not reveal a consensus resistance locus, although many have point mutations in genes encoding redox-relevant proteins such as superoxide dismutase (TgSOD2) and ribonucleotide reductase. We investigated the SOD2 L201P mutation and found that it was not sufficient to confer resistance when introduced into wild-type parasites. Resistant clones accumulated less ROS than their wild type counterparts. Our results demonstrate that resistance to auranofin in T. gondii enhances its ability to abate oxidative stress through diverse mechanisms. This evidence supports a hypothesized mechanism of auranofin anti-parasitic activity as disruption of redox homeostasis. Frontiers Media S.A. 2021-03-19 /pmc/articles/PMC8017268/ /pubmed/33816332 http://dx.doi.org/10.3389/fcimb.2021.618994 Text en Copyright © 2021 Ma, Tirtorahardjo, Jan, Schweizer, Rosario, Du, Zhang, Morrissette and Andrade http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Ma, Christopher I. Tirtorahardjo, James A. Jan, Sharon Schweizer, Sakura S. Rosario, Shawn A. C. Du, Yanmiao Zhang, Jerry J. Morrissette, Naomi S. Andrade, Rosa M. Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase |
title | Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase |
title_full | Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase |
title_fullStr | Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase |
title_full_unstemmed | Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase |
title_short | Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase |
title_sort | auranofin resistance in toxoplasma gondii decreases the accumulation of reactive oxygen species but does not target parasite thioredoxin reductase |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017268/ https://www.ncbi.nlm.nih.gov/pubmed/33816332 http://dx.doi.org/10.3389/fcimb.2021.618994 |
work_keys_str_mv | AT machristopheri auranofinresistanceintoxoplasmagondiidecreasestheaccumulationofreactiveoxygenspeciesbutdoesnottargetparasitethioredoxinreductase AT tirtorahardjojamesa auranofinresistanceintoxoplasmagondiidecreasestheaccumulationofreactiveoxygenspeciesbutdoesnottargetparasitethioredoxinreductase AT jansharon auranofinresistanceintoxoplasmagondiidecreasestheaccumulationofreactiveoxygenspeciesbutdoesnottargetparasitethioredoxinreductase AT schweizersakuras auranofinresistanceintoxoplasmagondiidecreasestheaccumulationofreactiveoxygenspeciesbutdoesnottargetparasitethioredoxinreductase AT rosarioshawnac auranofinresistanceintoxoplasmagondiidecreasestheaccumulationofreactiveoxygenspeciesbutdoesnottargetparasitethioredoxinreductase AT duyanmiao auranofinresistanceintoxoplasmagondiidecreasestheaccumulationofreactiveoxygenspeciesbutdoesnottargetparasitethioredoxinreductase AT zhangjerryj auranofinresistanceintoxoplasmagondiidecreasestheaccumulationofreactiveoxygenspeciesbutdoesnottargetparasitethioredoxinreductase AT morrissettenaomis auranofinresistanceintoxoplasmagondiidecreasestheaccumulationofreactiveoxygenspeciesbutdoesnottargetparasitethioredoxinreductase AT andraderosam auranofinresistanceintoxoplasmagondiidecreasestheaccumulationofreactiveoxygenspeciesbutdoesnottargetparasitethioredoxinreductase |